Evidence map›Paper›PMID 28013444›Full record

ReviewMetabolic brain disease2017

Current state of knowledge of hepatic encephalopathy (part IV): Management of Hepatic Encephalopathy by liver support systems.

Tarek Hassanein

Abstract readReview
PubMed Publisher
In one paragraph

Review in Metabolic brain disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Hepatic encephalopathy: current challenges and future prospects.Hepatic medicine : evidence and research · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Tarek HassaneinSouthern California Liver Centers, 131 Orange Avenue, Suite 101 Coronado, CA, 92118, USA. thassanein@livercenters.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic Encephalopathy is a devastating complication of End-Stage Liver Disease. In its severe grades it requires extra intervention beyond the standard medical approaches. In this article were view the role of liver support systems in managing hepatic encephalopthy.

Indexed as

Liver, ArtificialDisease ManagementEnd Stage Liver DiseaseHepatic EncephalopathyHumansLiver CirrhosisPlasma ExchangeRandomized Controlled Trials as TopicArtificial liver supportECADHepatic encephalopathyTreatment of hepatic encephalopathy

Identifiers

PMID28013444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.